ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716122 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716122; 2) Community: the network communities that were significantly associated with the response to NSC 716122; 3) Molecule: the relationships between components within communities and NSC 716122; 4) MDR: the compounds that were significantly associated with the NSC 716122.

NSC Compound Enrichment Correlation
NSC 673499 Null 0.022188614181866 0.24070974
NSC 679516 Null 0.022188614181866 0.35394566
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.022188614181866 0.13351616
NSC 693322 Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- 0.022188614181866 -0.13237181
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.022188614181866 0.054897175
NSC 716002 Null 0.022188614181866 0.35110816
NSC 718564 Null 0.022188614181866 -0.027635878
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.022188614181866 0.14888206
NSC 726217 Combretastatin A4-analogue 0.022188614181866 0.51699079
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.022188614181866 0.35181018
Total:111  Current:59    [First] [Prev] [Next] [Last]